We also report that upregulation of TRPV1 alleviates AD‐related neuropathologies and inhibits AMPAR endocytosis via interacting with GluA2 subunit, which may subsequently contribute to the amelioration of cognitive function and synaptic plasticity. The gene discussed is TRPV1; the disease is Alzheimer disease.